<?xml version="1.0" encoding="UTF-8"?><!-- generator="podbean/5.5" -->
<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
     xmlns:spotify="http://www.spotify.com/ns/rss"
     xmlns:podcast="https://podcastindex.org/namespace/1.0"
    xmlns:media="http://search.yahoo.com/mrss/">

<channel>
    <title>DOM Dialogues</title>
    <atom:link href="https://feed.podbean.com/domdialogues/feed.xml" rel="self" type="application/rss+xml"/>
    <link>https://domdialogues.podbean.com</link>
    <description><![CDATA[<p><em>DOM Dialogues</em> is the official podcast of the journal, <em>Diabetes, Obesity and Metabolism</em>, published by Wiley. Each episode brings leading experts together for accessible, conversational discussions on the latest developments across diabetes, obesity, and metabolic disease. From emerging therapies and clinical trial insights to real‑world practice implications, <em>DOM Dialogues </em>translates rigorous research into engaging, educational conversations. Designed for a global clinical and research audience, the podcast offers expert perspectives, critical context, and practical takeaways, helping listeners stay informed, curious, and connected to the science shaping metabolic health.</p>]]></description>
    <pubDate>Fri, 18 Sep 2026 17:01:42 +0100</pubDate>
    <generator>https://podbean.com/?v=5.5</generator>
    <language>en</language>
        <copyright>Copyright 2026 All rights reserved.</copyright>
    <category>Health &amp; Fitness:Medicine</category>
    <ttl>1440</ttl>
    <itunes:type>episodic</itunes:type>
          <itunes:summary></itunes:summary>
        <itunes:author>Wiley: Diabetes, Obesity and Metabolism</itunes:author>
	<itunes:category text="Health &amp; Fitness">
		<itunes:category text="Medicine" />
	</itunes:category>
    <itunes:owner>
        <itunes:name>Wiley: Diabetes, Obesity and Metabolism</itunes:name>
            </itunes:owner>
    	<itunes:block>No</itunes:block>
	<itunes:explicit>false</itunes:explicit>
    <itunes:image href="https://pbcdn1.podbean.com/imglogo/image-logo/22046715/Final_DOM_Dialogues-204872r28.jpg" />
    <image>
        <url>https://pbcdn1.podbean.com/imglogo/image-logo/22046715/Final_DOM_Dialogues-204872r28.jpg</url>
        <title>DOM Dialogues</title>
        <link>https://domdialogues.podbean.com</link>
        <width>144</width>
        <height>144</height>
    </image>
    <item>
        <title>Episode 3: Continuous Glucose Monitoring - Challenges in CGM Designing</title>
        <itunes:title>Episode 3: Continuous Glucose Monitoring - Challenges in CGM Designing</itunes:title>
        <link>https://domdialogues.podbean.com/e/4/</link>
                    <comments>https://domdialogues.podbean.com/e/4/#comments</comments>        <pubDate>Fri, 18 Sep 2026 17:01:42 +0100</pubDate>
        <guid isPermaLink="false">domdialogues.podbean.com/1ffad8f3-fa7f-34a0-8932-365a61be99fb</guid>
                                    <description><![CDATA[<p>Welcome to Wiley's DOM Dialogues Podcast, the podcast series brought to you from the journal, Diabetes, Obesity and Metabolism.  </p>
<p>This three-part audio podcast series is hosted by Professor Idris - Professor of Diabetes and Metabolic Medicine at the University of Nottingham and Honorary Consultant Physician and Endocrinologist at the University Hospitals of Derby and Burton Foundation Trust.  </p>
<p>The focus of this series is Continuous Glucose Monitoring (CGM) and covers key clinical, technical, and regulatory considerations. In this third and final episode, Dr. George Mallas and Dr. Tomas Walker will focus on the technical and design challenges behind CGM systems. </p>
<p> </p>
<p>Overview </p>
<p>00:07 Intro &amp; guest introductions </p>
<p>02:57 What a CGM actually measures </p>
<p>05:05 Reference measurements &amp; regulatory comparison standards </p>
<p>06:34 Underreading in the hyperglycemic range </p>
<p>07:06 Accuracy metrics — MARD and error grids </p>
<p>12:05 Closing messages </p>
<p> </p>
<p>This medical education activity is co-developed and supported by MiniMed.  </p>
<p>The content of these podcasts is intended for healthcare professionals only. </p>
<p> </p>
<p>Speaker - Dr. Tomas Walker is a semi-retired former VP Medical Affairs at Dexcom Inc. He is an accomplished clinician, researcher, and diabetes care expert with a distinguished career spanning nearly three decades. A nurse practitioner for more than 28 years, Dr. Walker is a certified diabetes care and education specialist and holds board certifications in both advanced diabetes management and family practice. He's passionate about patient empowerment and healthcare innovations and has published extensively on diabetes technology. </p>
<p>Speaker - Dr. George Mallas is a data science director in the sensor R&amp;D department of MiniMed, where he manages the team that develops the CGM algorithm, which calculates sensor glucose from sensor signals and generates glycaemic alerts. </p>
<p> </p>
<p>For more medical education from Wiley, please visit <a href='https://focus.wiley.com/'>https://focus.wiley.com/</a>  </p>
<p>Diabetes, Obesity and Metabolism is the only interdisciplinary journal for high-quality research and reviews in the areas of diabetes, obesity and metabolism. To access our latest publications, please visit <a href='https://dom-pubs.onlinelibrary.wiley.com/'>https://dom-pubs.onlinelibrary.wiley.com/</a> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Welcome to Wiley's DOM Dialogues Podcast, the podcast series brought to you from the journal, <em>Diabetes, Obesity and Metabolism</em>.  </p>
<p>This three-part audio podcast series is hosted by Professor Idris - Professor of Diabetes and Metabolic Medicine at the University of Nottingham and Honorary Consultant Physician and Endocrinologist at the University Hospitals of Derby and Burton Foundation Trust.  </p>
<p>The focus of this series is Continuous Glucose Monitoring (CGM) and covers key clinical, technical, and regulatory considerations. In this third and final episode, Dr. George Mallas and Dr. Tomas Walker will focus on the technical and design challenges behind CGM systems. </p>
<p> </p>
<p>Overview </p>
<p>00:07 Intro &amp; guest introductions </p>
<p>02:57 What a CGM actually measures </p>
<p>05:05 Reference measurements &amp; regulatory comparison standards </p>
<p>06:34 Underreading in the hyperglycemic range </p>
<p>07:06 Accuracy metrics — MARD and error grids </p>
<p>12:05 Closing messages </p>
<p> </p>
<p>This medical education activity is co-developed and supported by MiniMed.  </p>
<p>The content of these podcasts is intended for healthcare professionals only. </p>
<p> </p>
<p>Speaker - Dr. Tomas Walker is a semi-retired former VP Medical Affairs at Dexcom Inc. He is an accomplished clinician, researcher, and diabetes care expert with a distinguished career spanning nearly three decades. A nurse practitioner for more than 28 years, Dr. Walker is a certified diabetes care and education specialist and holds board certifications in both advanced diabetes management and family practice. He's passionate about patient empowerment and healthcare innovations and has published extensively on diabetes technology. </p>
<p>Speaker - Dr. George Mallas is a data science director in the sensor R&amp;D department of MiniMed, where he manages the team that develops the CGM algorithm, which calculates sensor glucose from sensor signals and generates glycaemic alerts. </p>
<p> </p>
<p>For more medical education from Wiley, please visit <a href='https://focus.wiley.com/'>https://focus.wiley.com/</a>  </p>
<p><em>Diabetes, Obesity and Metabolism</em> is the only interdisciplinary journal for high-quality research and reviews in the areas of diabetes, obesity and metabolism. To access our latest publications, please visit <a href='https://dom-pubs.onlinelibrary.wiley.com/'>https://dom-pubs.onlinelibrary.wiley.com/</a> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/emeqg6i7egfqbyxr/WLYPC_22_3_Audio_podcast_Aug_28_2026.mp3" length="14754443" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Welcome to Wiley's DOM Dialogues Podcast, the podcast series brought to you from the journal, Diabetes, Obesity and Metabolism.  
This three-part audio podcast series is hosted by Professor Idris - Professor of Diabetes and Metabolic Medicine at the University of Nottingham and Honorary Consultant Physician and Endocrinologist at the University Hospitals of Derby and Burton Foundation Trust.  
The focus of this series is Continuous Glucose Monitoring (CGM) and covers key clinical, technical, and regulatory considerations. In this third and final episode, Dr. George Mallas and Dr. Tomas Walker will focus on the technical and design challenges behind CGM systems. 
 
Overview 
00:07 Intro &amp; guest introductions 
02:57 What a CGM actually measures 
05:05 Reference measurements &amp; regulatory comparison standards 
06:34 Underreading in the hyperglycemic range 
07:06 Accuracy metrics — MARD and error grids 
12:05 Closing messages 
 
This medical education activity is co-developed and supported by MiniMed.  
The content of these podcasts is intended for healthcare professionals only. 
 
Speaker - Dr. Tomas Walker is a semi-retired former VP Medical Affairs at Dexcom Inc. He is an accomplished clinician, researcher, and diabetes care expert with a distinguished career spanning nearly three decades. A nurse practitioner for more than 28 years, Dr. Walker is a certified diabetes care and education specialist and holds board certifications in both advanced diabetes management and family practice. He's passionate about patient empowerment and healthcare innovations and has published extensively on diabetes technology. 
Speaker - Dr. George Mallas is a data science director in the sensor R&amp;D department of MiniMed, where he manages the team that develops the CGM algorithm, which calculates sensor glucose from sensor signals and generates glycaemic alerts. 
 
For more medical education from Wiley, please visit https://focus.wiley.com/  
Diabetes, Obesity and Metabolism is the only interdisciplinary journal for high-quality research and reviews in the areas of diabetes, obesity and metabolism. To access our latest publications, please visit https://dom-pubs.onlinelibrary.wiley.com/ 
 ]]></itunes:summary>
        <itunes:author>Wiley: Diabetes, Obesity and Metabolism</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>921</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>4</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <podcast:transcript url="https://mcdn.podbean.com/mf/web/dzzpajfupciqnw4x/8e9f761a-2dba-39fa-881c-83c9da02d117.srt" type="application/srt" />    </item>
    <item>
        <title>Episode 2: Continuous Glucose Monitoring - Challenges in Regulation</title>
        <itunes:title>Episode 2: Continuous Glucose Monitoring - Challenges in Regulation</itunes:title>
        <link>https://domdialogues.podbean.com/e/3/</link>
                    <comments>https://domdialogues.podbean.com/e/3/#comments</comments>        <pubDate>Fri, 18 Sep 2026 17:00:33 +0100</pubDate>
        <guid isPermaLink="false">domdialogues.podbean.com/53007c60-c83d-343e-b43e-041437837c3f</guid>
                                    <description><![CDATA[<p>Welcome to Wiley's DOM Dialogues Podcast, the podcast series brought to you from the journal, Diabetes, Obesity and Metabolism.  </p>
<p>This three-part audio podcast series is hosted by Professor Idris - Professor of Diabetes and Metabolic Medicine at the University of Nottingham and Honorary Consultant Physician and Endocrinologist at the University Hospitals of Derby and Burton Foundation Trust.  </p>
<p>The focus of this series is Continuous Glucose Monitoring (CGM) and covers key clinical, technical, and regulatory considerations. In this second episode, Professor Chantal Mathieu will examine the regulatory gaps in CGM evaluation and the need for greater standardization. </p>
<p> </p>
<p>Overview </p>
<p>00:07 Intro &amp; guest introduction </p>
<p>02:10 Gaps in CGM accuracy evaluation </p>
<p>06:42 US vs. Europe regulatory comparison </p>
<p>08:55 Path forward for CGM regulation </p>
<p>11:10 Closing message </p>
<p> </p>
<p>This medical education activity is co-developed and supported by MiniMed.  </p>
<p>The content of these podcasts is intended for healthcare professionals only. </p>
<p> </p>
<p>Speaker - Professor Chantal Mathieu is a physician-scientist and an internationally recognized expert in diabetes and endocrinology. Her basic research focuses on the pathogenesis and prevention of type 1 diabetes, including the immune effects of vitamin D. Her clinical research spans new products and treatment approaches in diabetes, type 1 diabetes screening and prevention, diabetes in pregnancy, new insulins and therapies, novel technologies, and adjunct treatments for type 1 diabetes. </p>
<p>Professor Mathieu coordinates INNODIA, the European clinical trial network for interventions in type 1 diabetes, as well as EDENT1FI, a European project focused on screening for type 1 diabetes. She is also President of the European Diabetes Forum, EUDF. She has supervised 30 doctoral theses and authored or co-authored more than 500 peer-reviewed publications in international journals. </p>
<p> </p>
<p>For more medical education from Wiley, please visit <a href='https://focus.wiley.com/'>https://focus.wiley.com/</a>  </p>
<p>Diabetes, Obesity and Metabolism is the only interdisciplinary journal for high-quality research and reviews in the areas of diabetes, obesity and metabolism. To access our latest publications, please visit <a href='https://dom-pubs.onlinelibrary.wiley.com/'>https://dom-pubs.onlinelibrary.wiley.com/</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Welcome to Wiley's DOM Dialogues Podcast, the podcast series brought to you from the journal, <em>Diabetes, Obesity and Metabolism</em>.  </p>
<p>This three-part audio podcast series is hosted by Professor Idris - Professor of Diabetes and Metabolic Medicine at the University of Nottingham and Honorary Consultant Physician and Endocrinologist at the University Hospitals of Derby and Burton Foundation Trust.  </p>
<p>The focus of this series is Continuous Glucose Monitoring (CGM) and covers key clinical, technical, and regulatory considerations. In this second episode, Professor Chantal Mathieu will examine the regulatory gaps in CGM evaluation and the need for greater standardization. </p>
<p> </p>
<p>Overview </p>
<p>00:07 Intro &amp; guest introduction </p>
<p>02:10 Gaps in CGM accuracy evaluation </p>
<p>06:42 US vs. Europe regulatory comparison </p>
<p>08:55 Path forward for CGM regulation </p>
<p>11:10 Closing message </p>
<p> </p>
<p>This medical education activity is co-developed and supported by MiniMed.  </p>
<p>The content of these podcasts is intended for healthcare professionals only. </p>
<p> </p>
<p>Speaker - Professor Chantal Mathieu is a physician-scientist and an internationally recognized expert in diabetes and endocrinology. Her basic research focuses on the pathogenesis and prevention of type 1 diabetes, including the immune effects of vitamin D. Her clinical research spans new products and treatment approaches in diabetes, type 1 diabetes screening and prevention, diabetes in pregnancy, new insulins and therapies, novel technologies, and adjunct treatments for type 1 diabetes. </p>
<p>Professor Mathieu coordinates INNODIA, the European clinical trial network for interventions in type 1 diabetes, as well as EDENT1FI, a European project focused on screening for type 1 diabetes. She is also President of the European Diabetes Forum, EUDF. She has supervised 30 doctoral theses and authored or co-authored more than 500 peer-reviewed publications in international journals. </p>
<p> </p>
<p>For more medical education from Wiley, please visit <a href='https://focus.wiley.com/'>https://focus.wiley.com/</a>  </p>
<p><em>Diabetes, Obesity and Metabolism</em> is the only interdisciplinary journal for high-quality research and reviews in the areas of diabetes, obesity and metabolism. To access our latest publications, please visit <a href='https://dom-pubs.onlinelibrary.wiley.com/'>https://dom-pubs.onlinelibrary.wiley.com/</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r4fkgymbm5w659yx/WLYPC_21_Audio_Podcast_July_14_2026.mp3" length="19001766" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Welcome to Wiley's DOM Dialogues Podcast, the podcast series brought to you from the journal, Diabetes, Obesity and Metabolism.  
This three-part audio podcast series is hosted by Professor Idris - Professor of Diabetes and Metabolic Medicine at the University of Nottingham and Honorary Consultant Physician and Endocrinologist at the University Hospitals of Derby and Burton Foundation Trust.  
The focus of this series is Continuous Glucose Monitoring (CGM) and covers key clinical, technical, and regulatory considerations. In this second episode, Professor Chantal Mathieu will examine the regulatory gaps in CGM evaluation and the need for greater standardization. 
 
Overview 
00:07 Intro &amp; guest introduction 
02:10 Gaps in CGM accuracy evaluation 
06:42 US vs. Europe regulatory comparison 
08:55 Path forward for CGM regulation 
11:10 Closing message 
 
This medical education activity is co-developed and supported by MiniMed.  
The content of these podcasts is intended for healthcare professionals only. 
 
Speaker - Professor Chantal Mathieu is a physician-scientist and an internationally recognized expert in diabetes and endocrinology. Her basic research focuses on the pathogenesis and prevention of type 1 diabetes, including the immune effects of vitamin D. Her clinical research spans new products and treatment approaches in diabetes, type 1 diabetes screening and prevention, diabetes in pregnancy, new insulins and therapies, novel technologies, and adjunct treatments for type 1 diabetes. 
Professor Mathieu coordinates INNODIA, the European clinical trial network for interventions in type 1 diabetes, as well as EDENT1FI, a European project focused on screening for type 1 diabetes. She is also President of the European Diabetes Forum, EUDF. She has supervised 30 doctoral theses and authored or co-authored more than 500 peer-reviewed publications in international journals. 
 
For more medical education from Wiley, please visit https://focus.wiley.com/  
Diabetes, Obesity and Metabolism is the only interdisciplinary journal for high-quality research and reviews in the areas of diabetes, obesity and metabolism. To access our latest publications, please visit https://dom-pubs.onlinelibrary.wiley.com/ ]]></itunes:summary>
        <itunes:author>Wiley: Diabetes, Obesity and Metabolism</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>786</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>3</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <podcast:transcript url="https://mcdn.podbean.com/mf/web/q5g7cqaywy482esa/27b6c937-5dee-35b4-b446-911f9ec5eea3.srt" type="application/srt" />    </item>
    <item>
        <title>Episode 1:  Continuous Glucose Monitoring - Challenges in Clinic</title>
        <itunes:title>Episode 1:  Continuous Glucose Monitoring - Challenges in Clinic</itunes:title>
        <link>https://domdialogues.podbean.com/e/2/</link>
                    <comments>https://domdialogues.podbean.com/e/2/#comments</comments>        <pubDate>Fri, 18 Sep 2026 12:11:59 +0100</pubDate>
        <guid isPermaLink="false">domdialogues.podbean.com/b202f2bd-619b-3d6b-8554-117f0a1bc43b</guid>
                                    <description><![CDATA[<p>Welcome to Wiley's DOM Dialogues Podcast, the podcast series brought to you from the journal, Diabetes, Obesity and Metabolism.  </p>
<p>This three-part audio podcast series is hosted by Professor Iskandar Idris - Professor of Diabetes and Metabolic Medicine at the University of Nottingham and Honorary Consultant Physician and Endocrinologist at the University Hospitals of Derby and Burton Foundation Trust.  </p>
<p>The focus of this series is Continuous Glucose Monitoring (CGM) and covers key clinical, technical, and regulatory considerations. In this first episode, Professor Tadej Battelino will explore the key clinical and scientific issues surrounding CGM use. The episode will also highlight how clinicians should evaluate the quality and consistency of new CGMs entering the market. </p>
<p> </p>
<p>Overview </p>
<p>00:09 Intro &amp; guest introduction </p>
<p>02:34 Main clinical challenges with CGM data </p>
<p>04:46 Evaluating quality/consistency of new CGM systems </p>
<p>05:48 Interpreting comparative evidence between CGM systems </p>
<p>07:29 Role of key opinion leaders / professional bodies </p>
<p>09:26 Closing message &amp; future outlook </p>
<p> </p>
<p>This medical education activity is co-developed and supported by MiniMed.  </p>
<p>The content of these podcasts is intended for healthcare professionals only. </p>
<p> </p>
<p>Speaker - Professor Tadej Battelino is currently Consultant and Head of Department of Endocrinology at UCH-UMC, Ljubljana, a clinical pharmacologist, Head, Chair of Pediatrics, and Professor of Pediatrics at Faculty of Medicine at the University of Ljubljana. His research focuses on diabetes, endocrinology, metabolism, and advanced diabetes technologies. With more than 455 peer-reviewed publications, his work has significantly shaped pediatric diabetes care and innovation. He has received several prestigious honors, including the Slovene national award for research, University of Ljubljana Gold Medal for research, the ISPAD Achievement Award, the European Society for Pediatric Endocrinology (ESPE) Research Award, and an international diabetes leadership award. He also serves as Chair of the International Diabetes Federation Europe and is a member of leading scientific academies and professional societies. </p>
<p> </p>
<p>For more medical education from Wiley, please visit <a href='https://focus.wiley.com/'>https://focus.wiley.com/</a>  </p>
<p>Diabetes, Obesity and Metabolism is the only interdisciplinary journal for high-quality research and reviews in the areas of diabetes, obesity and metabolism. To access our latest publications, please visit <a href='https://dom-pubs.onlinelibrary.wiley.com/'>https://dom-pubs.onlinelibrary.wiley.com/</a>  </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Welcome to Wiley's DOM Dialogues Podcast, the podcast series brought to you from the journal, <em>Diabetes, Obesity and Metabolism</em>.  </p>
<p>This three-part audio podcast series is hosted by Professor Iskandar Idris - Professor of Diabetes and Metabolic Medicine at the University of Nottingham and Honorary Consultant Physician and Endocrinologist at the University Hospitals of Derby and Burton Foundation Trust.  </p>
<p>The focus of this series is Continuous Glucose Monitoring (CGM) and covers key clinical, technical, and regulatory considerations. In this first episode, Professor Tadej Battelino will explore the key clinical and scientific issues surrounding CGM use. The episode will also highlight how clinicians should evaluate the quality and consistency of new CGMs entering the market. </p>
<p> </p>
<p>Overview </p>
<p>00:09 Intro &amp; guest introduction </p>
<p>02:34 Main clinical challenges with CGM data </p>
<p>04:46 Evaluating quality/consistency of new CGM systems </p>
<p>05:48 Interpreting comparative evidence between CGM systems </p>
<p>07:29 Role of key opinion leaders / professional bodies </p>
<p>09:26 Closing message &amp; future outlook </p>
<p> </p>
<p>This medical education activity is co-developed and supported by MiniMed.  </p>
<p>The content of these podcasts is intended for healthcare professionals only. </p>
<p> </p>
<p>Speaker - Professor Tadej Battelino is currently Consultant and Head of Department of Endocrinology at UCH-UMC, Ljubljana, a clinical pharmacologist, Head, Chair of Pediatrics, and Professor of Pediatrics at Faculty of Medicine at the University of Ljubljana. His research focuses on diabetes, endocrinology, metabolism, and advanced diabetes technologies. With more than 455 peer-reviewed publications, his work has significantly shaped pediatric diabetes care and innovation. He has received several prestigious honors, including the Slovene national award for research, University of Ljubljana Gold Medal for research, the ISPAD Achievement Award, the European Society for Pediatric Endocrinology (ESPE) Research Award, and an international diabetes leadership award. He also serves as Chair of the International Diabetes Federation Europe and is a member of leading scientific academies and professional societies. </p>
<p> </p>
<p>For more medical education from Wiley, please visit <a href='https://focus.wiley.com/'>https://focus.wiley.com/</a>  </p>
<p><em>Diabetes, Obesity and Metabolism</em> is the only interdisciplinary journal for high-quality research and reviews in the areas of diabetes, obesity and metabolism. To access our latest publications, please visit <a href='https://dom-pubs.onlinelibrary.wiley.com/'>https://dom-pubs.onlinelibrary.wiley.com/</a>  </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7mee4dsu9iwm58yi/WLYPC_23_6_Audio_Podcast_Sep_18_2026.mp3" length="12327113" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Welcome to Wiley's DOM Dialogues Podcast, the podcast series brought to you from the journal, Diabetes, Obesity and Metabolism.  
This three-part audio podcast series is hosted by Professor Iskandar Idris - Professor of Diabetes and Metabolic Medicine at the University of Nottingham and Honorary Consultant Physician and Endocrinologist at the University Hospitals of Derby and Burton Foundation Trust.  
The focus of this series is Continuous Glucose Monitoring (CGM) and covers key clinical, technical, and regulatory considerations. In this first episode, Professor Tadej Battelino will explore the key clinical and scientific issues surrounding CGM use. The episode will also highlight how clinicians should evaluate the quality and consistency of new CGMs entering the market. 
 
Overview 
00:09 Intro &amp; guest introduction 
02:34 Main clinical challenges with CGM data 
04:46 Evaluating quality/consistency of new CGM systems 
05:48 Interpreting comparative evidence between CGM systems 
07:29 Role of key opinion leaders / professional bodies 
09:26 Closing message &amp; future outlook 
 
This medical education activity is co-developed and supported by MiniMed.  
The content of these podcasts is intended for healthcare professionals only. 
 
Speaker - Professor Tadej Battelino is currently Consultant and Head of Department of Endocrinology at UCH-UMC, Ljubljana, a clinical pharmacologist, Head, Chair of Pediatrics, and Professor of Pediatrics at Faculty of Medicine at the University of Ljubljana. His research focuses on diabetes, endocrinology, metabolism, and advanced diabetes technologies. With more than 455 peer-reviewed publications, his work has significantly shaped pediatric diabetes care and innovation. He has received several prestigious honors, including the Slovene national award for research, University of Ljubljana Gold Medal for research, the ISPAD Achievement Award, the European Society for Pediatric Endocrinology (ESPE) Research Award, and an international diabetes leadership award. He also serves as Chair of the International Diabetes Federation Europe and is a member of leading scientific academies and professional societies. 
 
For more medical education from Wiley, please visit https://focus.wiley.com/  
Diabetes, Obesity and Metabolism is the only interdisciplinary journal for high-quality research and reviews in the areas of diabetes, obesity and metabolism. To access our latest publications, please visit https://dom-pubs.onlinelibrary.wiley.com/  ]]></itunes:summary>
        <itunes:author>Wiley: Diabetes, Obesity and Metabolism - A Journal of Pharmacology and Therapeutics</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>770</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>2</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <podcast:transcript url="https://mcdn.podbean.com/mf/web/3edhycqtshqbt4w8/15d693b6-f99e-3fd4-b19c-2b1a3cf6fe95.srt" type="application/srt" />    </item>
    <item>
        <title>Welcome to DOM Dialogues with Editor-in-Chief, Professor Richard Donnelly</title>
        <itunes:title>Welcome to DOM Dialogues with Editor-in-Chief, Professor Richard Donnelly</itunes:title>
        <link>https://domdialogues.podbean.com/e/1/</link>
                    <comments>https://domdialogues.podbean.com/e/1/#comments</comments>        <pubDate>Fri, 22 May 2026 09:52:30 +0100</pubDate>
        <guid isPermaLink="false">domdialogues.podbean.com/8c1979e5-4d9e-3a47-ba6b-9e8900dfeec3</guid>
                                    <description><![CDATA[<p>In this inaugural episode of DOM Dialogues, Editor-in-Chief Professor Richard Donnelly introduces the podcast and explores its purpose in bringing Diabetes, Obesity and Metabolism research to life. Through this opening conversation, he reflects on the journal’s evolution, highlights the need for accessible, real-world insights, and previews the key topics from emerging therapies to evolving clinical guidance, that listeners can expect in future episodes.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this inaugural episode of DOM Dialogues, Editor-in-Chief Professor Richard Donnelly introduces the podcast and explores its purpose in bringing Diabetes, Obesity and Metabolism research to life. Through this opening conversation, he reflects on the journal’s evolution, highlights the need for accessible, real-world insights, and previews the key topics from emerging therapies to evolving clinical guidance, that listeners can expect in future episodes.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wbnwwqb6hh9t2ddb/Wiley_-_DOM_Dialogues_Podcast_v2_2_9j04y.mp3" length="14084482" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this inaugural episode of DOM Dialogues, Editor-in-Chief Professor Richard Donnelly introduces the podcast and explores its purpose in bringing Diabetes, Obesity and Metabolism research to life. Through this opening conversation, he reflects on the journal’s evolution, highlights the need for accessible, real-world insights, and previews the key topics from emerging therapies to evolving clinical guidance, that listeners can expect in future episodes.]]></itunes:summary>
        <itunes:author>Wiley: Diabetes, Obesity and Metabolism - A Journal of Pharmacology and Therapeutics</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>584</itunes:duration>
        <itunes:season>1</itunes:season>
        <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
</channel>
</rss>
